Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Blueberry reports positive results from Phase I/II BB2603 trial

Nail infected with onychomycosis. Credit: KTesh.

  • Blueberry Therapeutics

Go Top